You shall report directly to Kites President and Chief Executive Officer.įollowing your relocation to Los Angeles, CA on or before January 7, 2013, your duties shall be performed primarily at Kites office, which is currently located 10924 Le Conte Avenue, Los Angeles, CA. Whether or not such business activity is pursued for gain, profit or other pecuniary advantage, that will interfere with the performance of your duties or your availability to perform such duties or that will adversely affect, or negatively reflect You shall devote substantially all of your business time, attention and energies to the business and affairs of Kite and shall not during the term of your employment be actively engaged in any other business activity, Kites process development and manufacturing capabilities and their timely implementation and such other duties as may be reasonably expected to be performed by a Vice President, Product Sciences as determined by Kites Chief Executive Surgery Branch of the National Cancer Institutes selection of qualified CMOs and vendors and advancing related contractual agreements oversight of product process transfer and manufacturing activities at CMO developing strategies to build Responsibilities will includeĭevelopment of product process optimization to achieve a short, closed GMP compliant process applicable for multi-center clinical trials and commercialization of eACT products coordination and oversight of the process optimization activities by the (Kite or the ∼ompany) is pleased to offer you the position of Vice President, Product Sciences on the followingĪs Vice President, Product Sciences for Kite, you will be responsible for leading Kites cell-based product development and manufacturing to advance Kites eACT product pipeline. Using our stock analysis tools, you can find out how much better you can do when adding Kite Pharma to your portfolios without increasing risk or reducing expected return.Kite Pharma, Inc. Optimizing your investment portfolio is an essential element in this goal. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.īe your own money managerAs an investor, your ultimate goal is to build wealth. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. To calculate Kite Pharma's market, we take the total number of its shares issued and multiply it by Kite Pharma's current market price. Market capitalization usually refers to the total value of a company's stock within the entire market. Kite Market CapitalizationThe company currently falls under 'Large-Cap' category with a current market capitalization of 10.31 B. Over 90.0% of the company shares are owned by institutional investors This results in cash-per-share (CPS) ratio of -4.5467. Kite Pharma currently holds about 781.11 M in cash with (155.8 M) of positive cash flow from operations. Net Loss for the year was (359.1 M) with profit before overhead, payroll, taxes, and interest of 22.17 M. The company reported the previous year's revenue of 32.14 M. Kite Pharma has a very high chance of going through financial distress in the upcoming years Kite Pharma has some characteristics of a very speculative penny stock Kite Pharma is not yet fully synchronised with the market data

Kite pharma inc stock